It is difficult, however, to establish a clear correlation between dopamine levels, LAT2/4F2hc expression, and the risk of hypertension in the context of CKD, even in view of the pleiotropic effects that dopamine and the SLC7A8/SLC3A2 genes exert. Here, SLC3A2 is linked to hypertensive disorder.